St. Clair Advisors’s AbbVie ABBV Stock Holding History

St. Clair Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,073	Closed	-$683K	–	80
2023 Q2	$683K	Hold	5,073	–	–	0.27%	49
2023 Q1	$808K	Hold	5,073	–	–	0.35%	43
2022 Q4	$820K	Buy	5,073 +2,452	+94%	+$376K	0.52%	27
2022 Q3	$352K	Hold	2,621	–	–	0.28%	28
2022 Q2	$401K	Sell	2,621 -398	-13%	-$60.8K	0.32%	26
2022 Q1	$489K	Hold	3,019	–	–	0.33%	26
2021 Q4	$409K	Sell	3,019 -322	-10%	-$38K	0.23%	38
2021 Q3	$360K	Buy	3,341 +322	+11%	+$36.8K	0.25%	37
2021 Q2	$340K	Hold	3,019	–	–	0.25%	35
2021 Q1	$327K	Hold	3,019	–	–	0.26%	32
2020 Q4	$323K	Buy	+3,019	New	+$290K	0.31%	33

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

St. Clair Advisors's ABBV Position: Q3 2023 in Review

St. Clair Advisors sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 5,073 shares — an estimated $683K sold.

St. Clair Advisors first reported a position in ABBV in Q4 2020 and held it in 11 quarters. The position peaked at $820K in Q4 2022. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

St. Clair Advisors reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
St. Clair Advisors sold 5,073 AbbVie shares in Q3 2023, an estimated $683K.
St. Clair Advisors first reported a position in AbbVie in Q4 2020 and held it in 11 quarters.
St. Clair Advisors's AbbVie position peaked at $820K in Q4 2022.
3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on St. Clair Advisors's 13F filing for Q3 2023, filed 10 Apr 2025.